-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$24.501625.35% Upside
ALX Oncology Holdings Inc. Frequently Asked Questions
-
What analysts cover ALX Oncology Holdings Inc.?
ALX Oncology Holdings Inc. has been rated by research analysts at UBS, Raymond James, Stifel Nicolaus, Credit Suisse in the past 90 days.